The OmniAI Brief
Subscribe
Sign in
Home
Weekly Edition
Alerts
Archive
About
AI is becoming simpler to use and harder to map
Microsoft wants one place to start. Cheaper models are creating more specialist products. Buzz shows how their agents may eventually work together.
4 hrs ago
•
Jorge Herrera
1
July 2026
Models are improving fast. Adoption still happens one useful product at a time.
Last week brought two more high-end AI models, OpenAI’s new enterprise voice product and wider U.S. access to ChatGPT Health. Here is what changed—and…
Jul 27
•
Jorge Herrera
3
ChatGPT Health moves AI inside the patient journey
Connected records turn a general chatbot into a personal interpretation layer—but not yet a healthcare administrator.
Jul 24
•
Jorge Herrera
2
AI is moving closer to the moment of action
Doceree’s commercial command layer, Europe’s open assistant ecosystem, and the models expanding who can build effective AI products.
Jul 20
•
Jorge Herrera
2
Europe is preparing Android for assistants that could filter what doctors see
The signal is not another launch. It is sustained physician use of proactive, multi-source medical help.
Jul 17
•
Jorge Herrera
The AI warning has changed
Economists are no longer asking whether AI will transform work. Pharma leaders should identify the commercial workflows their 2027 plans still assume…
Jul 14
•
Jorge Herrera
The next device will multiply the answers brands do not control
Ambient AI turns GEO from a search tactic into customer-engagement infrastructure.
Jul 13
•
Jorge Herrera
1
Muse raises the bar. It does not make your content factory ready.
Meta’s new image model gives pharma leaders a better way to test the promises already coming from agencies and technology vendors.
Jul 12
•
Jorge Herrera
AI just got a bigger engine. Pharma still needs a better transmission.
Weekly Edition example · What the new model cycle changes across pharma omnichannel—and what it does not.
Jul 11
•
Jorge Herrera
Veeva opened the journey door. Now somebody has to guard it.
Alert example · One consequential signal, the pharma-omnichannel decision it changes, and a two-minute call.
Jul 11
•
Jorge Herrera
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts